UKALL60+: identifying the standard of care for elderly patients with ALL
What are the benefits of having different chronic lymphocytic leukemia (CLL) treatment options?
Promising clinical trials for myeloproliferative neoplasms
Advancing cellular therapies for blood cancers
Reporting positive treatment outcomes with bendamustine + rituximab in indolent lymphomas